Quality-of-life in interventionally treated patients with post-thrombotic syndrome

被引:20
作者
Catarinella, F. S. [1 ]
Nieman, F. H. M. [2 ]
de Wolf, M. A. F. [1 ]
Toonder, I. M. [1 ]
de Graaf, R. [3 ]
Wittens, C. H. A. [1 ,4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Venous Surg, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Med Ctr, Clin Epidemiol & Med Technol Assessment, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Radiol, NL-6200 MD Maastricht, Netherlands
[4] Univ Klinikum, Dept Vasc Surg, Aachen, Germany
关键词
Quality-of-life; post-thrombotic syndrome; deep venous obstruction; percutaneous transluminal angioplasty; venous stent; Maastricht University Medical Centre; Maastricht; DEEP-VEIN THROMBOSIS; OUTCOMES;
D O I
10.1177/0268355515569431
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction New developments in the treatment of complex deep venous disease have become available in the last decade. Besides analysing patencies as a surrogate outcome for these treatments we analysed the Quality-of-Life (QoL) changes for successful and failed deep venous treatments. Materials and methods Patients with proven venous occlusive disease, referred to our department of Venous Surgery at the Maastricht University Medical Centre, were included. After inclusion patients were treated by percutaneous transluminal angioplasty and stenting and when indicated endophlebectomy with an arteriovenous fistula. QoL was assessed with the disease specific VEINES-QOL/Sym and the generic Short-Form (SF)-36 questionnaires preoperatively at baseline and post-operatively after 3, 12 and 24 months. Results One hundred fifty-three interventions were analysed, showing a primary, assisted primary and secondary patency of respectively 65%, 78% and 89% at 24 months. The VEINES-QOL and Sym scores improved at 3, 12 and 24 months. The overall improvement at 24 months is 22.7 for QoL and 18.18 for Sym with respective p values of 0.013 and 0.016. The improvement of the VEINES-QOL and Sym scores after a successful (patent) treatment remained highly significant (QoL: p<0.001, Sym: p=0.004). Also the generic QoL (Short-Form 36v2) shows significant improvement after 12 months for physical functioning (p=0.004) and role physical (p=0.004) scales. Conclusions The overall patencies of interventions for deep venous pathology are exceptionally good after two years. Concomitantly the VEINES-Sym and VEINES-QOL scores improve significantly for 3, 12, and 24 months when compared to the baseline (T0) after treatment. Successful interventions showed, as expected, a significant greater QoL improvement between T0 and T3, T12, T24 for both VEINES-QOL and VEINES-Sym scores when compared to the failed interventions. The one-year linear improvement of two SF-36 scales (PF and RP) is also significant.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 50 条
  • [1] Short-term follow-up of Quality-of-Life in interventionally treated patients with post-thrombotic syndrome after deep venous occlusion
    Catarinella, F. S.
    Nieman, F. H. M.
    de Wolf, M. A. F.
    Wittens, C. H. A.
    PHLEBOLOGY, 2014, 29 : 104 - 111
  • [2] Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome
    Lee, Angela
    Gu, Chu-Shu
    Vedantham, Suresh
    Kearon, Clive
    Blostein, Mark
    Kahn, Susan R.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2021, 9 (05) : 1257 - +
  • [3] Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban
    Ferreira, Tatiane
    Huber, Stephany Cares
    Martinelli, Beatriz de Moraes
    Lemos Junior, Arlindo
    Menezes, Fabio Husemann
    Orsi, Fernanda Andrade
    Bittar, Luis Fernando
    Gerbase de Oliveira, Luiz Frederico
    Sodre, Leonardo Ragazzi
    Mello, Tayana Teixeira
    Rielli, Glauber
    Colella, Marina Pereira
    de Paula, Erich Vinicius
    Yamaguti-Hayakawa, Gabriela G.
    Montalvao, Silmara
    Annichino-Bizzacchi, Joyce M.
    VASCULAR PHARMACOLOGY, 2020, 124
  • [4] Epidemiology of the post-thrombotic syndrome
    Galanaud, Jean-Philippe
    Monreal, Manuel
    Kahn, Susan R.
    THROMBOSIS RESEARCH, 2018, 164 : 100 - 109
  • [5] The post-thrombotic syndrome
    Kahn, Susan R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 413 - 418
  • [6] Prevention and treatment of the post-thrombotic syndrome
    ten Cate-Hoek, Nina J.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2018, 2 (02) : 209 - 219
  • [7] Prevention and Management of the Post-Thrombotic Syndrome
    Makedonov, Ilia
    Kahn, Susan R.
    Galanaud, Jean-Philippe
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [8] Prevention and treatment of the post-thrombotic syndrome
    Pikovsky, Oleg
    Rabinovich, Anat
    THROMBOSIS RESEARCH, 2018, 164 : 116 - 124
  • [9] Post-thrombotic syndrome in children
    Betensky, Marisol
    Goldenberg, Neil A.
    THROMBOSIS RESEARCH, 2018, 164 : 129 - 135
  • [10] Prevention of the Post-Thrombotic Syndrome
    Carman T.L.
    Current Treatment Options in Cardiovascular Medicine, 2016, 18 (8)